Primer group, micro-fluidic chip and kit for detecting multiple equine pathogenic viruses

By designing LAMP primer sets and microfluidic chips for a variety of equine pathogenic viruses, combined with loop-mediated isothermal amplification technology, the complex and time-consuming problems of existing virus detection methods are solved, and fast and accurate virus detection is achieved. Suitable for grassroots applications.

CN118979124APending Publication Date: 2024-11-19CHINA INST OF VETERINARY DRUG CONTROL

Patent Information

Application Number
CN202411246842.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing virus detection methods are complex, time-consuming and have many false positives, which cannot meet the simple, fast and accurate detection needs of disease prevention and control.

Method used

A set of LAMP primers for African horse plague virus, West Nile fever virus, Oriental equine encephalomyelitis virus, Western equine encephalomyelitis virus and Venezuelan equine encephalomyelitis virus were designed, combining microfluidic chips and kits , the ring-mediated isothermal amplification technology is used to judge the existence of the virus through changes in fluorescence values, reduce the possibility of contamination, and is suitable for on-site application.

Benefits of technology

It has achieved the detection of 10 copies of viral nucleic acids within 30 minutes, shortened the reaction time, improved the accuracy, sensitivity and specificity of the detection, and was suitable for rapid detection at the grassroots level.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979124A_ABST
    Figure CN118979124A_ABST
Patent Text Reader

Abstract

The invention provides a primer combination, a micro-fluidic chip and a kit for detecting multiple pathogenic viruses of horses, and belongs to the technical field of virus detection. A primer group for detecting multiple equine pathogenic viruses is designed on the basis of a loop-mediated isothermal amplification method and consists of a pair of outer primers, a pair of inner primers and a pair of loop primers. The LAMP technology serves as the core, the microfluidic chip technology is combined, the African horse pestivirus (AHS), the West Nile fever virus (WNV), the eastern equine encephalomyelitis virus (EEE), the West equine encephalomyelitis virus (WEE) and the Venezuela equine encephalomyelitis virus (VEE) can be detected at the same time, judgment can be conducted only according to changes of fluorescence values during detection, the reaction time is shortened, and the detection accuracy is improved. And the kit has the advantages of high accuracy, high sensitivity, strong specificity and in-situ application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of virus detection, and is specifically designed to be used for detecting a plurality of horse pathogenic viruses, a primer set, a microfluidic chip and a kit. Background Art

[0002] African horse sickness virus (AHS) is a disease that occurs in equine animals. Sick horses have fever, subcutaneous edema and viremia, and in severe cases, bleeding in tissues and organs. African horse sickness mainly occurs in Africa and is endemic in the Sahara region of Africa. It is a Class I animal disease in China. There is no effective treatment for African horse sickness. When a suspected case of African horse sickness is found, it should be reported in a timely manner in accordance with the provisions of laws and regulations. Take compulsory measures such as emergency control and eradication.

[0003] West Nile virus (WNV) belongs to the genus Flaviviridae and is a zoonotic disease. The serious harm of this disease is that it causes fatal encephalitis in humans and horses, and causes death in birds, chickens, etc. The incubation period of this disease is 3-15 days, and most infected horses do not show clinical symptoms. Sick horses show viral encephalitis or encephalomyelitis, fever, muscle tremors, mild to severe ataxia, inability to stand, blindness, grinding of teeth, lip paralysis, and acute death. The mortality rate is high, reaching more than 30%.

[0004] Equine encephalitis (including Eastern and Western types) belongs to the Togaviridae family, Alphavirus genus. The incubation period of equine encephalitis virus is 1-3 weeks, and the incidence rate in horses generally does not exceed 20%-30%. Sick horses have fever, followed by central nervous system symptoms. They are initially excited and restless, move in circles, bump into obstacles, and refuse to eat. They then become lethargic, stand against the wall with their heads down, but may suddenly startle and then fall into a wrong sleep state. Sick horses often assume abnormal postures such as dog sitting, and then show symptoms of paralysis. The lower lip droops and the tongue hangs out of the mouth. They stagger and finally fall dead. The course of the disease is 1-2 days. The mortality rate of Eastern equine encephalitis is sometimes as high as 90%, while the mortality rate of Western equine encephalitis is 20%-30%, sometimes as high as 50%.

[0005] Venezuelan equine encephalomyelitis (VEE) is a Class II infectious disease and parasitic disease. It is caused by the Venezuelan equine encephalomyelitis virus and is spread by arthropods. It is seasonal and mainly attacks the central nervous system. Venezuelan equine encephalomyelitis often presents a biphasic fever. In the first phase, the body temperature rises and there is viremia. In the second phase, there are central nervous system symptoms. In addition to high fever, there are ataxia, nystagmus, drooping lower lip, dehydration and collapse. This disease generally develops a heat reaction after a latent period of 24-72 hours. Clinically, the sick animals show depression, diarrhea, abdominal pain, rapid pulse, loss of appetite and rapid weight loss. When the condition improves slightly, the body temperature returns to normal after 2-4 days. Otherwise, the fever continues, the sick animals become increasingly weak, and most of them die within 2-4 days.

[0006] The above traditional virus detection methods mainly include the use of traditional culture medium method (pathogenic microorganism isolation and identification, morphological identification and automated identification methods), enzyme-linked immunosorbent assay, nucleic acid probe technology, nucleic acid amplification (PCR) technology, etc., but they all have shortcomings, such as the electron microscopy method is complex and expensive, the virus isolation and culture is extremely time-consuming and has many false positives. PCR detection methods have been widely used in clinical testing in recent years, such as conventional PCR, real-time fluorescence quantitative PCR, etc., which play an important role in the detection of pathogenic microorganisms and disease diagnosis, but they generally require instruments that can perform precise temperature control to perform advanced and complex analysis, and have high operating requirements for detection personnel and long reaction time, which is not conducive to grassroots promotion and cannot meet the simple, fast and accurate detection requirements for disease prevention and control. Summary of the invention

[0007] The invention provides a primer set, a microfluidic chip and a kit for detecting multiple equine pathogenic viruses, which have the advantages of short detection time, high accuracy, high sensitivity and strong specificity.

[0008] The invention provides a primer set for detecting horse pathogenic viruses, including a LAMP primer set designed for the conservative regions of African horse sickness virus, West Nile fever virus, Eastern equine encephalomyelitis virus, Western equine encephalomyelitis virus and Venezuelan equine encephalomyelitis virus.

[0009] Preferably, the conserved regions of the African horse sickness virus, West Nile fever virus, Eastern equine encephalitis virus, Western equine encephalitis virus and Venezuelan equine encephalitis virus are shown in SEQ ID No.31 to SEQ ID No.35, respectively.

[0010] Preferably, the nucleotide sequences designed for African horse sickness virus are the forward outer primer AHS-F3, the reverse outer primer AHS-B3, the forward inner primer AHS-FIP, the reverse inner primer AHS-BIP, the forward loop primer AHS-LF and the reverse loop primer AHS-LB as shown in SEQ ID No. 1 to SEQ ID No. 6;

[0011] The nucleotide sequences designed for West Nile virus are as shown in SEQ ID No.7 to SEQ ID No.12, namely, forward outer primer WNV-F3, reverse outer primer WNV-B3, forward inner primer WNV-FIP, reverse inner primer WNV-BIP, forward loop primer WNV-LF and reverse loop primer WNV-LB;

[0012] The nucleotide sequences designed for Eastern equine encephalitis virus are as shown in SEQ ID No. 13 to SEQ ID No. 18, namely, forward outer primer EEE-F3, reverse outer primer EEE-B3, forward inner primer EEE-FIP, reverse inner primer EEE-BIP, forward loop primer EEE-LF and reverse loop primer EEE-LB;

[0013] The nucleotide sequences designed for western equine encephalitis virus are as shown in SEQ ID No. 19 to SEQ ID No. 24, namely, forward outer primer WEE-F3, reverse outer primer WEE-B3, forward inner primer WEE-FIP, reverse inner primer WEE-BIP, forward loop primer WEE-LF and reverse loop primer WEE-LB;

[0014] The nucleotide sequences designed for Venezuelan equine encephalitis virus are shown in SEQ ID No. 25 to SEQ ID No. 30, namely, forward outer primer VEE-F3, reverse outer primer VEE-B3, forward inner primer VEE-FIP, reverse inner primer VEE-BIP, forward loop primer VEE-LF and reverse loop primer VEE-LB.

[0015] The invention provides a LAMP reagent for detecting horse pathogenic viruses, comprising a mixture of primer sets designed for different viruses in the above primer set and other reagents for preparing a LAMP system.

[0016] Preferably, the concentration of the forward outer primer in the mixed solution is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse forward primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

[0017] Preferably, the concentration of the forward outer primer in the mixed solution is 0.3-0.5 μM, the concentration of the reverse outer primer is 1-2 μM, the concentration of the forward inner primer and the reverse forward primer are both 2.4-3.4 μM, and the concentration of the forward loop primer and the reverse loop primer are both 1-2 μM.

[0018] Preferably, the other reagents for preparing the LAMP system include LAMP freeze-dried system Mix.

[0019] The present invention also provides the use of the primer set or the LAMP reagent in preparing a kit for simultaneously detecting multiple horse pathogenic viruses.

[0020] The present invention also provides a microfluidic chip for simultaneously detecting multiple horse pathogenic viruses, comprising: each reaction well of the microfluidic chip is coated with one of the above-mentioned LAMP primer sets or LAMP reagents.

[0021] The present invention also provides a kit for simultaneously detecting multiple horse pathogenic viruses, comprising the above-mentioned microfluidic chip.

[0022] Preferably, the types of horse pathogenic viruses include African horse sickness virus, West Nile fever virus, Eastern equine encephalitis virus, Western equine encephalitis virus and Venezuelan equine encephalitis virus.

[0023] Beneficial effect: The present invention provides a primer set for detecting a variety of horse pathogenic viruses, which is designed based on the method of loop-mediated isothermal amplification. The primer set of the virus consists of a pair of outer primers, a pair of inner primers and a pair of loop primers, wherein the outer primers are composed of F3 and B3, the inner primers are composed of FIP and BIP, and the loop primers are composed of LF and LB.

[0024] The present invention takes LAMP technology as the core, combines microfluidic chip technology, and can simultaneously detect five viruses: African horse sickness virus (AHS), West Nile fever virus (WNV), Eastern equine encephalitis virus (EEE), Western equine encephalitis virus (WEE) and Venezuelan equine encephalitis virus (VEE), and during detection, it only needs to be judged according to the change of fluorescence value, and the entire LAMP reaction process does not need to be opened, which greatly reduces the possibility of contamination and has a prospect for local application. The detection method of the present invention can greatly accelerate the reaction, can detect 10 copies of viral nucleic acid within 30 minutes, shorten the reaction time, and has high accuracy, high sensitivity and strong specificity. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is a structural diagram of the microfluidic chip of the present invention;

[0026] Figure 2Negative fluorescence curves of African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus LAMP method; in the figure, IC represents internal reference, AHS represents African horse sickness virus, WNV represents West Nile fever virus, EEE represents Eastern equine encephalomyelitis virus, WEE represents Western equine encephalomyelitis virus, VEE represents Venezuelan equine encephalomyelitis virus, and NC represents blank control;

[0027] Figure 3 The sensitivity fluorescence curve of the LAMP method for African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus at 10 copies / μL;

[0028] Figure 4 The sensitivity fluorescence curve of the LAMP method for African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus at 100 copies / μL;

[0029] Figure 5 The sensitivity fluorescence curve of the LAMP method for African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus at 1000 copies / μL;

[0030] Figure 6 This is the WNV simulation sample test result diagram. The left side of the diagram indicates a concentration of 10 copies / μL, and the right side indicates a concentration of 100 copies / μL.

[0031] Figure 7 This is the test result of EEE simulation sample. The left side of the figure indicates the concentration of 10 copies / μL, and the right side indicates the concentration of 100 copies / μL.

[0032] Figure 8 This is the WEE simulation sample test result diagram. The left side of the diagram indicates a concentration of 10 copies / μL, and the right side indicates a concentration of 100 copies / μL.

[0033] Fig. 9 This is the test result of VEE simulation sample. The left side of the figure indicates the concentration of 10 copies / μL, and the right side indicates the concentration of 100 copies / μL.

[0034] Fig.10 This is a picture of the test results of a negative horse blood sample;

[0035] Fig.11 This is the test result of African horse sickness virus AHS standard. The left side of the figure represents the concentration of 10 copies / μL, and the right side represents the concentration of 100 copies / μL. DETAILED DESCRIPTION

[0036] The present invention provides a set of primers for detecting multiple horse pathogenic viruses, including LAMP primers designed for the conserved regions of African horse sickness virus (AHS), West Nile virus (WNV), Eastern equine encephalitis virus (EEE), Western equine encephalitis virus (WEE) and Venezuelan equine encephalitis virus (VEE).

[0037] The present invention designs and screens a set of primers with good amplification efficiency by comparing the known genomes of African horse sickness virus, West Nile fever virus and equine encephalomyelitis virus. The conserved regions of the present invention are shown in SEQ ID No.31 to SEQ ID No.36, and a LAMP primer set is designed.

[0038] Table 1 Target regions of primer designs of the present invention

[0039]

[0040] The primers are composed of a pair of outer primers, a pair of inner primers and a pair of loop primers, wherein the outer primers are composed of F3 and B3, the inner primers are composed of FIP and BIP, and the loop primers are composed of LF and LB.

[0041] The primer combination involved in the present invention includes the following sequences:

[0042] The first group, African horse sickness virus (AHS) primer set:

[0043] Forward outer primer F3 (SEQ ID No. 1): TAGCTGATGTGTATGCGG;

[0044] Reverse outer primer B3 (SEQ ID No. 2): GTATTCGGTATTGACGTA;

[0045] Forward internal primer FIP (SEQ ID No. 3): CCGCAGCCACTAGTGGTAGGCTAGATTTCAGAATGAATGGTGTT;

[0046] Reverse inner primer BIP (SEQ ID No. 4): TGCACGGTCACCGCTTTCATTATACTTATGCGTACTTTATCAGC;

[0047] Forward loop primer LF (SEQ ID No. 5): CTAGCACAAGAGCTCT;

[0048] Reverse loop primer LB (SEQ ID No. 6): TCGCGTCGGTTCTTAT;

[0049] The second group, West Nile virus (WNV) primer set:

[0050] Forward outer primer F3 (SEQ ID No. 7): CCGCGGATTGTCCTTGAT;

[0051] Reverse outer primer B3 (SEQ ID No. 8): GGTCAGAGTTCCTAGTTC;

[0052] Forward inner primer FIP (SEQ ID No. 9): TCTGAAAAACGCCAAAAGAGCCAGGACTGAAGAGGGCTATGCTG;

[0053] Reverse inner primer BIP (SEQ ID No. 10): TGCGGTGCTGGACAGATGGAGACTTGAAACTCAAGAGATGCTTC;

[0054] Forward loop primer LF (SEQ ID No. 11): ACACGAAACGTATTGG;

[0055] Reverse loop primer LB (SEQ ID No. 12): TCAACAAACAAACAGC;

[0056] Group 3, Equine Encephalitis Virus (Eastern) (EEE) Primer Set:

[0057] Forward outer primer F3 (SEQ ID No. 13): TACGGAGTGTACTTATGC;

[0058] Reverse outer primer B3 (SEQ ID No. 14): GTGCAGACCTGCAGCTTA;

[0059] Forward internal primer FIP (SEQ ID No. 15): GGAGAATGAATTGGACAGTTTCCTTCCGATTTCGGTGGTATAGCCACC;

[0060] Reverse inner primer BIP (SEQ ID No. 16): TCAGGTGTTGCAGTTATTAAAGAGCAGGATGGATGTTTGCAGTGGAGA;

[0061] Forward loop primer LF (SEQ ID No. 17): ACTGGATTTGTAGGCA;

[0062] Reverse loop primer LB (SEQ ID No. 18): GGATCATTTACATTCC;

[0063] Group 4, equine encephalomyelitis virus (Western) (WEE) primer set:

[0064] Forward outer primer F3 (SEQ ID No. 19): CCTTACCAGCCACGGGCT;

[0065] Reverse outer primer B3 (SEQ ID No. 20): GGTCTACTTCTGCCTCTA;

[0066] Forward inner primer FIP (SEQ ID No. 21): GCTCCACATCGGCCATTGTAATAGCTTCCGCCGTAGGCTCAAGCTGCT;

[0067] Reverse inner primer BIP (SEQ ID No 22): TGAAGAAGTGGCTGCAGCGGAAGACTCTTTTTCTATTTCAGGGAGCAA;

[0068] Forward loop primer LF (SEQ ID No. 23): CGGGTTTGACAGTTGG;

[0069] Reverse loop primer LB (SEQ ID No. 24): TCAGAGAAGCCCTGCC;

[0070] Group 5, Venezuelan Equine Encephalomyelitis (VEE) Primer Group:

[0071] Forward outer primer F3 (SEQ ID No. 25): GAGCTGGCACCTGCCGTCTG;

[0072] Reverse outer primer B3 (SEQ ID No. 26): TGCGCGTCGTCCGCACTGAC;

[0073] Forward internal primer FIP (SEQ ID No. 27): CTCCCCGTTCAATGTGTCTGTCACTGAGACTATAGTTAGTTGCGACG;

[0074] Reverse inner primer BIP (SEQ ID No. 28): TCTTTTCCCGTGTGCACGTATGTGATCTGTTGCCAGTATGCCAGTCAT;

[0075] Forward loop primer LF (SEQ ID No. 29): TGCAGCACAGAATCCCT;

[0076] Reverse loop primer LB (SEQ ID No. 30): AGCTACATTGTGTGACCA.

[0077] The invention provides a LAMP reagent for detecting multiple horse pathogenic viruses, comprising a mixed solution of primer sets designed for different viruses in the above primer sets and other reagents for preparing the LAMP system.

[0078] The concentration of the forward outer primer in the mixed solution of the present invention is preferably 0.1-1 μM, more preferably 0.3-0.5 μM; the concentration of the reverse outer primer is preferably 0.1-5 μM, more preferably 1-2 μM; the concentrations of the forward inner primer and the reverse forward primer are preferably both 0.1-5 μM, more preferably 2.4-3.4 μM; the concentrations of the forward loop primer and the reverse loop primer are preferably both 0.1-3 μM, more preferably 1-2 μM.

[0079] The other reagents for preparing the LAMP system of the present invention preferably include a LAMP freeze-dried system Mix. In the embodiment, the freeze-dried system Mix in the LAMP amplification kit (freeze-dried type) is preferably used as an example for illustration, and the freeze-dried kit is preferably purchased from Beijing Taihao Biotechnology Co., Ltd., with a product number of THR-KZ-8-96.

[0080] The present invention also provides the use of the primer set or the LAMP reagent in preparing a kit for simultaneously detecting multiple horse pathogenic viruses.

[0081] The present invention combines the LAMP primer set with a microfluidic chip to meet the requirements of simultaneous detection of the above five viruses.

[0082] The present invention also provides a microfluidic chip for simultaneously detecting multiple horse pathogenic viruses, comprising: each reaction well of the microfluidic chip is coated with one of the above-mentioned LAMP detection indicators.

[0083] The microfluidic chip of the present invention preferably has 8 reaction wells, and each reaction well is coated with a LAMP primer set of a different virus. Figure 1 As shown, the indicators are arranged in order from left to right. Wells 1-7 represent blank control (NC), African horse sickness virus (AHS), West Nile virus (WNV), equine encephalomyelitis (eastern) (EEE), equine encephalomyelitis (western) (WEE), Venezuelan equine encephalomyelitis (VEE) and internal control (IC), respectively.

[0084] The present invention also provides a kit for simultaneously detecting multiple horse pathogenic viruses, comprising the above-mentioned microfluidic chip.

[0085] When the present invention uses the kit for detection, it is preferred to use the nucleic acid extracted from the blood as a template, perform LAMP reaction in a microfluidic chip, and use a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to detect the fluorescence value. The LAMP system of the present invention preferably includes, in 25 μL, a freeze-dried system Mix, F30.1~1 μM, B30.1~5 μM, FIP and BIP 0.1~5 μM each, LF and LB 0.1~3 μM each; more preferably includes: F30.3~0.5 μM, B31~2 μM, FIP and BIP 2.4~3.4 μM each, LF and LB 1~2 μM each. Using African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus gene plasmid DNA as templates, the fluorescence value is detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.)

[0086] The procedure of the LAMP reaction of the present invention preferably includes 65° C. for 30 min.

[0087] To further illustrate the present invention, the primer combination and microfluidic chip for detecting various horse pathogenic viruses provided by the present invention are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.

[0088] The DNA plasmids used in the embodiments of the present invention are five plasmids commissioned by Bioengineering to synthesize the conserved region genes of AHS, WNV, EEE, WEE and VEE shown in Table 1; the LAMP amplification kit (lyophilized type) was purchased from Beijing Taihao Biotechnology Co., Ltd. (THR-KZ-8-96); the microfluidic chip (8 reaction wells) was purchased from Beijing Taihao Biotechnology Co., Ltd. (THR-XP-S-8-01).

[0089] Example 1

[0090] (1) Using the five plasmids synthesized by Shenggong Biotechnology as positive templates and sterilized water as negative templates, 25 μL of LAMP reaction system were prepared respectively: freeze-dried system Mix, F3 0.5 μM, B3 1 μM, FIP and BIP 2.5 μM each, LF and LB 1 μM each. Using African horse sickness virus, West Nile fever virus, and equine encephalomyelitis virus gene plasmid DNA as templates, the fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.).

[0091] (2) The five plasmid DNAs were diluted 10-fold, and three samples with concentration gradients of 1000 copies / μL, 100 copies / μL, and 10 copies / μL were taken for LAMP reaction in a microfluidic chip. The fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the sensitivity of the detection.

[0092] Among them: using sterile water as a template, LAMP reaction was carried out in a microfluidic chip, and the fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the negative reaction of the primer;

[0093] Negative test results such as Figure 2 As shown, it shows that the negative result of the detection method established by the present invention is good; the sensitivity detection result is as shown Figures 3 to 5 As shown, the detection method established by the present invention has a minimum detection limit of 10 copies of the target nucleic acid within 30 minutes.

[0094] (3) Simulation sample test

[0095] Horse blood samples were collected and added with West Nile virus and equine encephalomyelitis virus plasmid DNA to prepare simulated samples. Three simulated samples with concentration gradients of 100 copies / μL, 10 copies / μL, and negative were tested in a microfluidic chip. The fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the anti-interference performance of the detection system.

[0096] The experimental results of the simulated samples are shown in Figures 6 to 10 As shown, the detection method established by the present invention has strong detection specificity and high sensitivity in a real sample environment.

[0097] (4) Standard product testing

[0098] African horse sickness virus standard (provided by China Veterinary Drug Administration, number: GBW(E)091272), horse blood samples were collected, and the African horse sickness standard was added to prepare simulated samples. Three simulated samples with concentration gradients of 100 copies / μL, 10 copies / μL, and negative were tested in a microfluidic chip, and the fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the anti-interference performance of the detection system.

[0099] The experimental results of standard substances are as follows Fig.11 As shown, the detection method established by the present invention has strong specificity and high sensitivity.

[0100] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A set of primers for detecting equine pathogenic viruses, It is characterized in that Includes LAMP primer sets designed for the conserved regions of African horse sickness virus, West Nile fever virus, Eastern equine encephalitis virus, Western equine encephalitis virus and Venezuelan equine encephalitis virus.

2. The primer set according to claim 1, It is characterized in that The sequences of the conservative regions of the African horse sickness virus, West Nile fever virus, Eastern equine encephalomyelitis virus, Western equine encephalomyelitis virus and Venezuelan equine encephalomyelitis virus are shown in SEQ ID No.31 to SEQ ID No.35 respectively.

3. The primer set according to claim 1 or 2, It is characterized in that The nucleotide sequences designed for African horse sickness virus are as shown in SEQ ID No. 1 to SEQ ID No. 6, namely, forward outer primer AHS-F3, reverse outer primer AHS-B3, forward inner primer AHS-FIP, reverse inner primer AHS-BIP, forward loop primer AHS-LF and reverse loop primer AHS-LB; The nucleotide sequences designed for West Nile virus are as shown in SEQ ID No.7 to SEQ ID No.12, namely, forward outer primer WNV-F3, reverse outer primer WNV-B3, forward inner primer WNV-FIP, reverse inner primer WNV-BIP, forward loop primer WNV-LF and reverse loop primer WNV-LB; The nucleotide sequences designed for Eastern equine encephalitis virus are as shown in SEQ ID No. 13 to SEQ ID No. 18, namely, forward outer primer EEE-F3, reverse outer primer EEE-B3, forward inner primer EEE-FIP, reverse inner primer EEE-BIP, forward loop primer EEE-LF and reverse loop primer EEE-LB; The nucleotide sequences designed for western equine encephalitis virus are as shown in SEQ ID No. 19 to SEQ ID No. 24, namely, forward outer primer WEE-F3, reverse outer primer WEE-B3, forward inner primer WEE-FIP, reverse inner primer WEE-BIP, forward loop primer WEE-LF and reverse loop primer WEE-LB; The nucleotide sequences designed for Venezuelan equine encephalitis virus are shown in SEQ ID No. 25 to SEQ ID No. 30, namely, forward outer primer VEE-F3, reverse outer primer VEE-B3, forward inner primer VEE-FIP, reverse inner primer VEE-BIP, forward loop primer VEE-LF and reverse loop primer VEE-LB.

4. A LAMP reagent for detecting multiple pathogenic viruses in horses, It is characterized in that The invention comprises a mixture of primer sets designed for different viruses in the primer set described in any one of claims 1 to 3 and other reagents for preparing the LAMP system.

5. The LAMP reagent according to claim 4, It is characterized in that The concentration of the forward outer primer in the mixed solution is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse forward primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

6. The LAMP reagent according to claim 4, It is characterized in that The other reagents for preparing the LAMP system include LAMP freeze-dried system Mix.

7. Use of the primer set according to any one of claims 1 to 3 or the LAMP reagent according to any one of claims 4 to 6 in the preparation of a kit for simultaneously detecting multiple horse pathogenic viruses.

8. A microfluidic chip for simultaneous detection of multiple equine pathogenic viruses. It is characterized in that The method comprises coating each reaction well of the microfluidic chip with one of the primer sets according to any one of claims 1 to 3 or the LAMP reagents according to any one of claims 3 to 6.

9. A kit for simultaneously detecting multiple horse pathogenic viruses. It is characterized in that Comprising the microfluidic chip as described in claim 8.

10. The kit according to claim 9, It is characterized in that The types of horse pathogenic viruses include African horse sickness virus, West Nile fever virus, Eastern equine encephalomyelitis virus, Western equine encephalomyelitis virus and Venezuelan equine encephalomyelitis virus.

Citation Information

Patent Citations

  • Primer, amplification reaction liquid, kit and detection method for African horse plague LAMP detection

    CN112831611A

  • Primer probe group and micro-fluidic chip for detecting nine viruses

    CN117487964A

  • Assays for detection of mayaro virus and methods of detection thereof

    WO2024059501A1

Cited By

  • Dual RT-ddPCR detection method for eastern and western equine encephalomyelitis virus

    CN121538351A